Author: Lunai Bioworks Inc.

News

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson’s Disease Data Readout Targeted for First Half of 2027

August 6, 2026
Lunai Bioworks Inc.
No Comments

New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational validation, biomarker development, and pharmaceutical…

News

Lunai Bioworks is able to completely regress both primary and metastatic pancreatic tumors in preclinical humanized models, representing a breakthrough in allogeneic cancer immunotherapy

November 10, 2025
Lunai Bioworks Inc.
No Comments

Lunai Bioworks announces publication of second-generation allogeneic dendritic cell therapy platform in Vaccines. /PRNewswire/ — Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense…